Medication overuse and drug addiction: a narrative review from addiction perspective

Chronic headache is particularly prevalent in migraineurs and it can progress to a condition known as medication overuse headache (MOH). MOH is a secondary headache caused by overuse of analgesics or other medications such as triptans to abort acute migraine attacks. The worsening of headache sympto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of headache and pain 2021-04, Vol.22 (1), p.32-11, Article 32
Hauptverfasser: Takahashi, Tatiane Teru, Ornello, Raffaele, Quatrosi, Giuseppe, Torrente, Angelo, Albanese, Maria, Vigneri, Simone, Guglielmetti, Martina, Maria De Marco, Cristiano, Dutordoir, Camille, Colangeli, Enrico, Fuccaro, Matteo, Di Lenola, Davide, Spuntarelli, Valerio, Pilati, Laura, Di Marco, Salvatore, Van Dycke, Annelies, Abdullahi, Ramla Abuukar, Maassen van den Brink, Antoinette, Martelletti, Paolo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Chronic headache is particularly prevalent in migraineurs and it can progress to a condition known as medication overuse headache (MOH). MOH is a secondary headache caused by overuse of analgesics or other medications such as triptans to abort acute migraine attacks. The worsening of headache symptoms associated with medication overuse (MO) generally ameliorates following interruption of regular medication use, although the primary headache symptoms remain unaffected. MO patients may also develop certain behaviors such as ritualized drug administration, psychological drug attachment, and withdrawal symptoms that have been suggested to correlate with drug addiction. Although several reviews have been performed on this topic, to the authors best knowledge none of them have examined this topic from the addiction point of view. Therefore, we aimed to identify features in MO and drug addiction that may correlate. We initiate the review by introducing the classes of analgesics and medications that can cause MOH and those with high risk to produce MO. We further compare differences between sensitization resulting from MO and from drug addiction, the neuronal pathways that may be involved, and the genetic susceptibility that may overlap between the two conditions. Finally, ICHD recommendations to treat MOH will be provided herein.
ISSN:1129-2369
1129-2377
DOI:10.1186/s10194-021-01224-8